Background: Endometriosis is often related to debilitating pelvic pain and infertility. Hence, understanding/identifying the molecular mechanisms behind endometriosis is crucial for improving diagnosis and developing better treatment options.

Methods: In this study, a closer assessment of the proteomic profiles of normal endometrial stem cells (ESCs) and those derived from endometriosis (EESCs) was carried out, comparing them to bone marrow mesenchymal stem cells (MSCs).

Results: Notable differences were observed in protein expression across these three cell types. Accordingly, they identified specific protein markers like albumin, HSP27, KRT1, CALU, GSTP1, and GAPDH, which are all tied to processes such as cell migration, metastasis, and tissue stress. Interestingly, the protein patterns in ESCs were quite similar to those in MSCs, suggesting that ESCs could be promising candidates for future cell-based therapies. On the other hand, the unique and distinct expression of proteins like albumin and HSP27 in EESCs points to their role in the complex pathophysiology of endometriosis, particularly through mechanisms related to angiogenesis and inflammation. Moreover, the deeper bioinformatics analysis indicated that pathways associated with immune regulation and metabolic activity were enriched. It raises the possibility that endometriosis may increase the risk of certain cancers, underscoring the need for continued research into biomarkers and targeted therapies.

Conclusion: This research sheds new light on the molecular underpinnings of endometriosis and emphasizes the importance of proteomic approaches in enhancing diagnostic and treatment strategies. It’s a step forward in understanding a condition that affects so many women and could lead to more effective interventions.